Skip to content

Hosted by Dailymotion. For legal issues: Copyright Center · DMC · Instant Removal

Valeant — spotting the dangers | Lex

F
Financial Times

2 Views • Mar 04, 2019

Description

Canadian drugmaker Valeant has lost billions off its market value after questions over its drug pricing and accounting. Rob Armstrong, head of Lex, reviews the warning signs for the pharmaceuticals group.

► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs

For more video content from the Financial Times, visit http://www.FT.com/video

Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes